Requires pharmaceutical manufacturers and wholesale distributors to report certain manufacturing and dispensing information concerning prescription opioid drugs, medication-assisted treatment drugs, and opioid antidote drugs.*
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2018
Committee Review
Floor Vote
Governor
Introduced Apr 5, 2018
Last action Jun 17, 2019
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
2
Jun 17, 2019
Committee
Referred to Senate Budget and Appropriations Committee
upper
Jun 17, 2019
Upper · Passed
Reported out of Senate Committee with Amendments, 2nd Reading
upper
Apr 5, 2018
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2387
Scope: NJ
Hi! I can help you understand S 2387. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline